drugset / Trial / NCT00284271
Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is designed to test (1) feasibility and efficiancy of new BACOPP regimen and (2) toxicity, overall response and FFTF.
Timeline
- Start
- 2004-01
- Primary completion
- 2005-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adramycin | Unknown | — | — |
| Subject | Bleomycin | Unknown | — | — |
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | Vincristine | Small molecule | — | — |
| Subject | procarbazine | Small molecule | — | — |
| Background | Erythropoietin Beta | Protein / enzyme biologic | — | — |